To further evaluate TOPK as a potential target in MM cells, fresh bone marrow aspirates (BMA) from patients with MM were separated into CD138+ and CD138− fractions by magnetic selection and analyzed by Western blot along with PBMCs from the same patients (Figure 1B). This evidence concerns the gene PBK and Miyoshi myopathy.